Victory Capital Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
Other funds holding AXSM
Victory Capital Management's AXSM Position: Q3 2026 in Review
Victory Capital Management increased its Axsome Therapeutics (AXSM) stake by 1.5% in Q3 2026, buying an estimated $16.1K and bringing the position to 5,052 shares worth $932K. The position accounts for ﹤0.01% of the portfolio, ranked #1964.
Victory Capital Management first reported a position in AXSM in Q3 2019 and has held it in 24 quarters since. The position peaked at $1.42M in Q4 2019. 463 funds tracked by Wall St. Rank hold AXSM as of Q3 2026.
- Victory Capital Management held 5,052 shares of Axsome Therapeutics worth $932K as of Q3 2026.
- Victory Capital Management bought 74 Axsome Therapeutics shares in Q3 2026, an estimated $16.1K.
- Axsome Therapeutics made up ﹤0.01% of Victory Capital Management's portfolio in Q3 2026, its #1964 holding.
- Victory Capital Management first reported a position in Axsome Therapeutics in Q3 2019 and has held it in 24 quarters since.
- Victory Capital Management's Axsome Therapeutics position peaked at $1.42M in Q4 2019.
- 463 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2026.
Based on Victory Capital Management's 13F filing for Q3 2026, filed 10 Nov 2026.